1. Home
  2. MPAA vs ACET Comparison

MPAA vs ACET Comparison

Compare MPAA & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPAA
  • ACET
  • Stock Information
  • Founded
  • MPAA 1968
  • ACET 1947
  • Country
  • MPAA United States
  • ACET United States
  • Employees
  • MPAA N/A
  • ACET N/A
  • Industry
  • MPAA Auto Parts:O.E.M.
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPAA Consumer Discretionary
  • ACET Health Care
  • Exchange
  • MPAA Nasdaq
  • ACET Nasdaq
  • Market Cap
  • MPAA 155.8M
  • ACET 93.1M
  • IPO Year
  • MPAA 1994
  • ACET N/A
  • Fundamental
  • Price
  • MPAA $7.82
  • ACET $0.87
  • Analyst Decision
  • MPAA
  • ACET Strong Buy
  • Analyst Count
  • MPAA 0
  • ACET 4
  • Target Price
  • MPAA N/A
  • ACET $5.67
  • AVG Volume (30 Days)
  • MPAA 63.8K
  • ACET 580.3K
  • Earning Date
  • MPAA 02-07-2025
  • ACET 11-06-2024
  • Dividend Yield
  • MPAA N/A
  • ACET N/A
  • EPS Growth
  • MPAA N/A
  • ACET N/A
  • EPS
  • MPAA N/A
  • ACET N/A
  • Revenue
  • MPAA $739,413,000.00
  • ACET N/A
  • Revenue This Year
  • MPAA $8.91
  • ACET N/A
  • Revenue Next Year
  • MPAA $6.99
  • ACET N/A
  • P/E Ratio
  • MPAA N/A
  • ACET N/A
  • Revenue Growth
  • MPAA 5.20
  • ACET N/A
  • 52 Week Low
  • MPAA $4.36
  • ACET $0.81
  • 52 Week High
  • MPAA $10.40
  • ACET $3.77
  • Technical
  • Relative Strength Index (RSI)
  • MPAA 56.49
  • ACET 38.48
  • Support Level
  • MPAA $7.59
  • ACET $0.85
  • Resistance Level
  • MPAA $8.22
  • ACET $0.98
  • Average True Range (ATR)
  • MPAA 0.37
  • ACET 0.07
  • MACD
  • MPAA -0.06
  • ACET 0.00
  • Stochastic Oscillator
  • MPAA 49.04
  • ACET 28.10

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: